EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Continuous Global Improvement of Human Papillomavirus (HPV) Genotyping Services: The 2022 and 2023 HPV LabNet International Proficiency Studies

Laila Sara Arroyo Mühr iD, Carina Eklund, Camilla Lagheden, Emel Yilmaz, Ola Forslund, Marina Lilja, Joakim Dillner iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Laila Sara Arroyo Mühr und 6 weiteren Autor:innen. Beteiligte Einrichtung: International HPV Reference Center, Center for Cervical Cancer Elimination, Stockholm, Sweden. Hauptthemen laut MEDLINE: Papillomavirus Infections, Genotyping Techniques, Papillomaviridae, Genotype. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded through user fees from the PP program, the Swedish Cancer Society (grant number 20 1198 PjF 01 H), and the Bill and Melinda Gates Foun…, Gates Foundation, Cancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The International Human Papillomavirus (HPV) Reference Center launches annual global HPV genotyping proficiency panels to enhance the precision and international standardization of HPV genotyping services. This study aims to assess the proficiency levels achieved in the global HPV genotyping proficiency panels conducted in 2022 and 2023, and to evaluate trends in performance over time. The proficiency panels comprised 44 blinded samples each, including 40 samples containing various purified plasmids corresponding to HPV types combined with human DNA, plus four control samples (one negative control and three extraction controls). Proficiency required a sensitivity of 50 International Units (IU)/5 µL for HPV 16 and HPV 18 500 IU/5 µL for HPVs 6, 11, 31, 33, 45, 52, and 58 and 500 genome equivalents (GE)/5 µL for other HPV types in both single and multiple infections, while avoiding false positivity. In 2022, 78 laboratories submitted a total of 154 data sets, and in 2023, 81 laboratories contributed 141 data sets. Most data sets (87%, 258/295) utilized commercially available HPV assays. Proficiency was common, with 77% of data sets meeting the proficiency criteria in 2022 and 79% in 2023. False positive results significantly decreased from 22% in 2022 to 13% in 2023. The high proficiency and increasing specificity in HPV genotyping services indicates progress toward more reliable HPV testing. High accuracy is crucial for supporting global efforts in HPV and cervical cancer elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsGenotyping TechniquesPapillomaviridaeGenotypeLaboratory Proficiency TestingHumansGlobal HealthSensitivity and SpecificityHuman Papillomavirus Viruses

Stichwörter der Autor:innen

International HPV Reference Centerhuman papillomavirusinternational standardsproficiency panelsproficiency studies

Autor:innen und Institutionen

  • International HPV Reference Center, Center for Cervical Cancer Elimination, Stockholm, Sweden.
  • Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • EQUALIS AB, Uppsala, Sweden.

ORCID-Profile: Laila Sara Arroyo Mühr, Joakim Dillner

Förderung

  • This research was funded through user fees from the PP program, the Swedish Cancer Society (grant number 20 1198 PjF 01 H), and the Bill and Melinda Gates Foun…
  • Gates Foundation
  • Cancerfonden

Zitieren

APA

Arroyo Mühr, L. S., Eklund, C., Lagheden, C., Yilmaz, E., Forslund, O., Lilja, M., & Dillner, J. (2024). Continuous Global Improvement of Human Papillomavirus (HPV) Genotyping Services: The 2022 and 2023 HPV LabNet International Proficiency Studies. Journal of Medical Virology. https://doi.org/10.1002/jmv.70022

Vancouver

Arroyo Mühr LS, Eklund C, Lagheden C, Yilmaz E, Forslund O, Lilja M, et al. Continuous Global Improvement of Human Papillomavirus (HPV) Genotyping Services: The 2022 and 2023 HPV LabNet International Proficiency Studies. Journal of Medical Virology. 2024. doi:10.1002/jmv.70022

BibTeX
@article{ArroyoMhr2024,
  author = {Arroyo Mühr, Laila Sara and Eklund, Carina and Lagheden, Camilla and Yilmaz, Emel and Forslund, Ola and Lilja, Marina and Dillner, Joakim},
  title = {Continuous Global Improvement of Human Papillomavirus (HPV) Genotyping Services: The 2022 and 2023 HPV LabNet International Proficiency Studies},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70022}
}
Kostenlos starten →